NIFTY23,3670.21%
SENSEX74,2430.16%
BANKNIFTY54,4960.35%
NIFTY IT29,0100.99%
PHARMA24,2480.29%
AUTO26,1660.08%
FMCG48,3020.18%
METAL13,2221.60%
REALTY768.900.56%
ENERGY40,3460.25%
NIFTY23,3670.21%
SENSEX74,2430.16%
BANKNIFTY54,4960.35%
NIFTY IT29,0100.99%
PHARMA24,2480.29%
AUTO26,1660.08%
FMCG48,3020.18%
METAL13,2221.60%
REALTY768.900.56%
ENERGY40,3460.25%

Midcap Stocks Deliver Solid Returns Amidst Unfavourable Market Conditions

The strength visible in midcap stocks has helped several mutual funds from the segment deliver solid returns for their investors at a time when the mainboard indices are languishing due to the West Asia crisis. Despite an unfavourable macro setup, the Nifty Midcap 150 index had risen to its 52-week high late last month, with a year-to-date (YTD) gain of 3.61%.

According to data from the Association of Mutual Funds of India (AMFI), investors poured ₹6,551.40 crore into mid-cap funds in April, a record inflow of 8% on a monthly basis. In contrast, large-cap funds saw inflows drop 15.3% to ₹2,525 crore as investors sought opportunities beyond India's blue-chip firms.

Top Performing Midcap Funds YTD

Read also: Stock Picks for Monday, June 8: Sumeet Bagadia Recommends Three Buys

Several mutual funds from the midcap space have delivered up to 10% returns so far this year, shows data from ACE Mutual Fund. Here are the top performing midcap funds YTD:

RankFund NameYTD GainNAVAUM (₹ crore)Expense Ratio
1HSBC Midcap Fund9.65%441.3513,4003.6%
2ICICI Pru Midcap Fund5.4%332.287,5001.53%
3JM Midcap Fund4.61%19.871,1602.31%
4Quant Midcap Fund4.3%218.067,9001.8%
5Mahindra Manulife Midcap Fund4.1%35.214,6001.61%

The HSBC Midcap Fund has emerged as the leading midcap fund so far in 2026, with a 9.65% increase. It has a net asset value (NAV) of ₹441.35 and assets under management (AUM) of ₹13,400 crore. However, the expense ratio of the fund is high at 3.6%. The fund has delivered solid gains, rising 18% in a year, 104% in three years, and 410% in ten years.

The ICICI Pru Midcap Fund follows in the second spot with a return of 5.4%. The fund has an NAV of ₹332.28 and an AUM of ₹7,500 crore. Its expense ratio is significantly lower than HSBC Midcap Fund at 1.53%. The fund has also delivered competitive returns on a longer time frame, rising 14% in the last one year, 96% in three years, and 401% in ten years.

Read also: Oil Discovers Second Natural Gas Reserve in Andaman Offshore Block, Enhancing Regional Exploration Prospects

According to analysts, the midcap performance can be attributed to several factors, including stronger-than-expected corporate results for Q4FY26, technical recovery from oversold territory, and lower valuations. Vinod Nair, Head of Research at Geojit Investments Limited, noted that the one-year forward price-to-earnings ratio for midcaps has fallen below the five-year average of 26x, encouraging the ongoing upside. However, he emphasized that for this momentum to be sustained, two key developments are necessary: a reversal in FIIs' sell strategy in India and a reduction in earnings setbacks estimated for H1FY27.

Investor Takeaway

Investors may consider allocating to midcap mutual funds for potential gains.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.